Pittsburgh medical marijuana dispensary offers glimpse behind the scenes |
Local News

Pittsburgh medical marijuana dispensary offers glimpse behind the scenes

Ben Schmitt
Ben Schmitt
Cannabis consultant Sara Gullickson shows off her necklace with a marijuana leaf pendant at Solevo Wellness medical marijuana dispensary in Squirrel Hill.

Step inside Solevo Wellness in Pittsburgh for legalized medical marijuana vape pens, tinctures, oils and capsules.

The 7,000 square-foot Squirrel Hill dispensary resembles any standard medical clinic with soft blue walls, bright lights, a reception area and airy waiting room with televisions and literature on medical marijuana.

Visitors to the Squirrel Hill marijuana dispensary, scheduled to open Feb. 15, will be greeted by a receptionist, show their necessary legal paperwork to gain access to products and visit with a pharmacist. Then they’ll head to a showroom, where cannabis product samples are kept inside glass cases, make a purchase and continue with their day.

“The facility is absolutely beautiful,” said national cannabis consultant Sara Gullickson, who is working with Solevo on its finishing touches. “Our goal is to not only be clean and pristine, but make sure we are welcoming everybody to experience our facility and really get educated on the new school of medical marijuana.”

Gullickson on Wednesday toured a Tribune-Review reporter and photographer through what will be the first dispensary to open in Pittsburgh.

Solevo is in a formerly vacant building that stands alone near the Squirrel Hill Tunnel on Forward Avenue. Gullickson showed off the inventory rooms, soon to be full of medical marijuana products, and its high-tech security operation. The dispensary is constantly monitored by cameras.

“The first time people come in here, they don’t know what to expect,” Gullickson said. “They think it’s going to be like a sleazy pot shop or something and so we always want to show off that next level of care that makes this an enjoyable experience for everybody.”

.lemonwhale-embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width:100%; }.lemonwhale-embed-container iframe { position: absolute; top: 0; left:0; width: 100%; height: 100%; }

Solevo’s first shipment of medical marijuana will arrive soon from grower-processor Cresco Yeltrah in Brookville , Jefferson County, about 100 miles northeast of Pittsburgh, Gullickson said.

Gov. Tom Wolf signed a medical marijuana bill into law in April 2016. Medical marijuana in Pennsylvania will be available in pills, oils, tinctures or ointments. The Health Department is regulating the program, which forbids smoking marijuana in dry leaf form.

Under state law, patients can apply for a state-issued medical marijuana card if a doctor certifies they have one of 17 qualified medical conditions, included epilepsy, cancer, Crohn’s disease, multiple sclerosis and seizure disorders.

Qualified patients with a doctor’s recommendation will receive a Pennsylvania medical marijuana identification card, allowing the purchase of medical marijuana from an authorized state-licensed medical marijuana dispensary. Dispensaries are also allowed to sell equipment, such as vaping devices for liquid forms, to administer medical marijuana.

Under federal law, marijuana remains a Schedule 1 controlled substance, similar to heroin. Because of the federal classification, the Pennsylvania market operates on a cash basis, without insurance.

Dr. Rachel Levine, the acting health secretary and physician general, has called on the federal government to reclassify marijuana and pave the way for more research.

“The fact that marijuana is labeled a Schedule I compound, limits the research,” she told the Trib last week, explaining the federal classification means that the drug has no medical benefits. “One of the biggest issues we’re dealing with is the way marijuana is scheduled.”

Levine said she expects the medical marijuana program to be running statewide by May.

“Every week we have more growers and processors approved,” she said. “The program is progressing very well.”

Gullickson, who works for a company called Dispensary Permits, said Solevo will employ about 15 people.

Ben Schmitt is a Tribune-Review staff writer. Reach him at 412-320-7991, [email protected] or via Twitter at @Bencschmitt.

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.